Cargando…

Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia

BACKGROUND: The persistence of minimal residual disease (MRD) during therapy is the strongest adverse prognostic factor in acute lymphocytic leukemia (ALL). This study was to identify serum candidate peptides for monitoring MRD in adult ALL. RESULTS: A total of 33 peptides in the molecular weight ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Ju, He, Aili, Huang, Chen, Yang, Juan, Zhang, Wanggang, Wang, Jianli, Yang, Yun, Zhang, Pengyu, Zhang, Yang, Zhou, Fuling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195909/ https://www.ncbi.nlm.nih.gov/pubmed/25317080 http://dx.doi.org/10.1186/s12953-014-0049-y

Ejemplares similares

Correction to: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
por: Bai, Ju, et al.
Publicado: (2020)

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling
por: Bai, Ju, et al.
Publicado: (2013)

Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia
por: SONG, WEI, et al.
Publicado: (2013)

C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia
por: Lei, Bo, et al.
Publicado: (2017)

Prokaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technology
por: Zhang, Yang, et al.
Publicado: (2017)

Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia
por: Tu, Honglei, et al.
Publicado: (2016)

Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/β-catenin signaling pathway
por: Zhang, Pengyu, et al.
Publicado: (2017)

Gene rearrangement study for minimal residual disease monitoring in children with acute lymphocytic leukemia
por: Assumpção, Juliana Godoy, et al.
Publicado: (2013)

Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma
por: Bai, Ju, et al.
Publicado: (2019)

Immunological effects of vaccines combined with granulocyte colony-stimulating factor on a murine WEHI-3 leukemia model
por: Chen, Jinqiu, et al.
Publicado: (2017)

Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia
por: Wen, Qiaojun, et al.
Publicado: (2013)

Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
por: Del Giudice, Ilaria, et al.
Publicado: (2019)

Analysis of the Yeast Peptidome and Comparison with the Human Peptidome
por: Dasgupta, Sayani, et al.
Publicado: (2016)

Long non-coding RNA RPPH1 promotes the proliferation, invasion and migration of human acute myeloid leukemia cells through down-regulating miR-330-5p expression
por: Lei, Bo, et al.
Publicado: (2019)

Minimal Information About an Immuno‐Peptidomics Experiment (MIAIPE)
por: Lill, Jennie R., et al.
Publicado: (2018)

Minimal Residual Disease in Chronic Lymphocytic Leukemia: Highlights From SOHO 2020
Publicado: (2021)

MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia
por: Lei, Bo, et al.
Publicado: (2020)

Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting
por: Ringelstein-Harlev, Shimrit, et al.
Publicado: (2014)

Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia
por: Chen, Xiaoyan, et al.
Publicado: (2021)

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
por: Cumbo, Cosimo, et al.
Publicado: (2020)

Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia
por: Nachmias, Boaz, et al.
Publicado: (2022)

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study
por: Ma, Xiaorong, et al.
Publicado: (2016)

Serum peptidome profiles immune response of COVID-19 Vaccine administration
por: Zhang, Wenjia, et al.
Publicado: (2022)

Apelin affects the mouse aging urinary peptidome with minimal effects on kidney
por: Vinel, Claire, et al.
Publicado: (2019)

Influence of Honeybee Sting on Peptidome Profile in Human Serum
por: Matysiak, Jan, et al.
Publicado: (2015)

MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1
por: Qian, Lu, et al.
Publicado: (2016)

Comparative Peptidomics Analysis of Milk Fermented by Lactobacillus helveticus
por: Gao, Shuman, et al.
Publicado: (2022)

The plasma peptidome
por: Dufresne, Jaimie, et al.
Publicado: (2018)

Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia
por: Zhao, Shenglong, et al.
Publicado: (2022)

Flow Cytometry and Polymerase Chain Reaction-Based Analyses of Minimal Residual Disease in Chronic Lymphocytic Leukemia
por: Uhrmacher, Sabrina, et al.
Publicado: (2010)

Illumination of PRRSV Cytotoxic T Lymphocyte Epitopes by the Three-Dimensional Structure and Peptidome of Swine Lymphocyte Antigen Class I (SLA-I)
por: Pan, Xiaocheng, et al.
Publicado: (2020)

Magnetic Bead-Based Serum Peptidome Profiling in Patients with Gestational Diabetes Mellitus
por: Ai, Tingting, et al.
Publicado: (2015)

Analysis of serum peptidome patterns of patients stung by honey bees
por: Sui, Weiguo, et al.
Publicado: (2013)

Serum Peptidomic Profile as a Novel Biomarker for Rheumatoid Arthritis
por: Abdelati, Abeer A., et al.
Publicado: (2020)

Significance of the Differential Peptidome in Multidrug-Resistant Tuberculosis
por: Yang, Yan, et al.
Publicado: (2019)

Overexpression of G6PD and HSP90 Beta in Mice with Benzene Exposure Revealed by Serum Peptidome Analysis
por: Zhang, Juan, et al.
Publicado: (2015)

MALDI‐TOF‐MS analysis in low molecular weight serum peptidome biomarkers for NSCLC
por: Song, Yufan, et al.
Publicado: (2022)

Artificial Intelligence Enhances Diagnostic Flow Cytometry Workflow in the Detection of Minimal Residual Disease of Chronic Lymphocytic Leukemia
por: Salama, Mohamed E., et al.
Publicado: (2022)

Measurable residual disease in chronic lymphocytic leukemia
por: Benintende, Giulia, et al.
Publicado: (2023)

High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study
por: Ma, Xiaorong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dr1a1v6sens16ncvksr395k1c4